Afiba Manza‐A. Agovi

Author

Also Known As

A. Manza-A. Agovi, Afiba Manza-A Agovi, Afiba Manza-A. Agovi, Afiba Manza-Azele Agovi, Afiba Manza‐A. Agovi, M-A Agovi, Manza A. Agovi, Manza A. Agovi-Johnson, Manza-A Agovi, Manza-A. Agovi

Publications

710

Citations

H-Index

Concepts

All Affiliations

Medical College of Wisconsin University Hospitals Cleveland Medical Center Massachusetts General Hospital Princess Margaret Cancer Centre National Marrow Donor Program

About

Afiba Manza‐A. Agovi is an author at Medical College of Wisconsin specializing in marrow transplantation, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	206
2	Immunology	4	4	206
3	Health Sciences	2	2	42
4	Blood Transplantation	2	2	105
5	Cellular Therapies	1	1	24

Afiba Manza‐A. Agovi

Publications

679

Citations

H-Index

Page 1

	Year	Citations
Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made? John Horan, Brent R. Logan, Afiba Manza‐A. Agovi, Journal of Clinical Oncology	2011	195
Second Unrelated Donor Hematopoietic Cell Transplantation for Primary Graft Failure Jeffrey Schriber, Afiba Manza‐A. Agovi, Vincent T. Ho, Biology of Blood and Marrow Transplantation	2010	99
Outcomes following HSCT Using Fludarabine, Busulfan, and Thymoglobulin: A Matched Comparison to Allogeneic Transplants Conditioned with Busulfan and Cyclophosphamide Christopher Bredeson, Mei‐Jie Zhang, Afiba Manza‐A. Agovi, Biology of Blood and Marrow Transplantation ImmunologyImmunotherapyHsct Using FludarabineAllogeneic TransplantsChronic Gvhd	2008	87
Effects of spleen status on early outcomes after hematopoietic cell transplantation Görgün Akpek, Marcelo C. Pasquini, Brent R. Logan, Bone Marrow Transplantation Spleen StatusTransplantationMarrow TransplantationHematologyImmunology	2012	77
Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myelogenous Leukemia (AML) in Adults Willis H. Navarro, Afiba Manza‐A. Agovi, Brent R. Logan, Biology of Blood and Marrow Transplantation	2010	76
Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation David H. McDermott, Susan E. Conway, Tao Wang, Blood	2010	37
Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system Afiba Manza‐A. Agovi, Ifedioranma Anikpo, Matthew J. Cvitanovich, Preventive Medicine Reports	2020	27
Childhood Obesity and Outcomes after Bone Marrow Transplantation for Patients with Severe Aplastic Anemia Collin Barker, Afiba Manza‐A. Agovi, Brent R. Logan, Biology of Blood and Marrow Transplantation	2010	26
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia Joseph P. Uberti, Afiba Manza‐A. Agovi, Sergey Tarima, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationMedicineStem Cell Transplantation	2010	24
Unrelated Donor Allogeneic Transplantation after Failure of Autologous Transplantation for Acute Myelogenous Leukemia: A Study from the Center for International Blood and Marrow Transplantation Research James M. Foran, Steven Z. Pavletic, Brent R. Logan, Biology of Blood and Marrow Transplantation ImmunologyTransplantation MedicineAutologous TransplantationMyeloid NeoplasiaHematological Malignancy	2013	18

Page 1